SRPT Crashes After DMD Deaths, SLDB Gains on Promising Trial Data
Sarepta Therapeutics Today SRPT Sarepta Therapeutics $21.61 +0.05Â (+0.23%) As of 01:25 PM Eastern This is a fair market…
Capricor: High-Reward DMD Treatment Bet, Strong Data And Looming FDA Decision
This article was written by Follow With a background as an RN and an MBA, Stephen analyzes healthcare…
Can Solid Biosciences Disrupt the DMD Market?
When it comes to treating Duchenne muscular dystrophy (DMD), big news recently surfaced. DMD is a muscle disease.…